.png "AstraZeneca Gets CDSCO Approval for Durvalumab-Based Therapy")
AstraZeneca Pharma India has received CDSCO approval for Durvalumab with FLOT chemotherapy, making it the first perioperative immunotherapy option for adults with resectable gastric and gastroesophageal junction cancer.
Indoco Remedies has received USFDA approval for its ANDA for Lacosamide Oral Solution, a generic version of Vimpat. The approval strengthens the company’s growing footprint in the U.S. generics market.
.png "Novo Nordisk's Obesity Drug CagriSema Beats Wegovy In Trial")
Novo Nordisk said today that its next-generation obesity drug CagriSema delivered better weight loss and blood sugar control than Wegovy in a late-stage diabetes trial, strengthening its pipeline in the fast-growing market.
Eli Lilly and Repertoire Immune Medicines have joined forces in a $1.93B deal to develop next-gen autoimmune therapies, aiming to restore immune balance without broad suppression.
Union Budget 2026 boosts India’s biopharma and healthcare sectors with Rs 10,000 crore for Biopharma SHAKTI, creating new opportunities for innovation, manufacturing, and patient care.
Alembic Pharmaceuticals has received final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%, used to treat post-surgery eye inflammation and anterior uveitis, further strengthening its US generics portfolio.
.png "Sun Pharma focuses on US innovation amid generics slowdown")
Sun Pharma is working to stabilize its US generics business as manufacturing issues ease, while pushing innovation-led growth, specialty launches, and preparing for the day-one launch of generic semaglutide in India.
Pharma stocks are soaring after the Budget 2026 announcement of a Rs 10,000 crore biopharma push. This move under the Biopharma Shakti initiative is set to strengthen India's role in global healthcare, driving investment and innovation.
Biocon Biologics has secured a credit rating upgrade from S&P Global Ratings to BB+, reflecting a simpler capital structure, improved financial discipline, and steady growth outlook in the global biosimilars market.
In a first-of-its-kind initiative, Gleneagles Hospital has introduced an AI-enabled Hub-and-Spoke stroke model that connects diagnostic centers across Mumbai and Navi Mumbai to its stroke team in real time, helping detect strokes early, reduce...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")